Barry McDermott

Co-Founder & Scientific Advisor

BSc (Pharm), MPSI, MVB, BEng, PhD

Barry is a Co-Founder of Relevium Medical and has played a pivotal role in the development of RM-010 from its earliest stages. He was instrumental in creating the original inventive concepts underpinning the technology, leading prototype development, and establishing the in vitro models and preclinical test protocols that were critical to advancing the programme. Barry continues to provide scientific and strategic guidance when needed, leveraging his extensive experience in drug development, innovation, and translational research.